Healthcare Triangle Inc   (HCTI)
Other Ticker:  
Price: $2.1999 $0.29 15.178%
Day's High: $2.1999 Week Perf: 0.45 %
Day's Low: $ 1.95 30 Day Perf: 9.45 %
Volume (M): 64 52 Wk High: $ 10.89
Volume (M$): $ 140 52 Wk Avg: $2.73
Open: $1.99 52 Wk Low: $0.22

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 1
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Healthcare Triangle Inc

On August 30, 2010, Hybrid Coating Technologies Inc. consummated an August 16, 2010 Stock Purchase Agreement (the “Stock Purchase Agreement”) with Nanotech Industries International Inc., (“Nanotech”) a Nevada corporation located in Daly City, California. A previous January 31, 2010 agreement with Nanotech Industries Inc. (“NTI”), a related party of Nanotech, was terminated on August 16, 2010 prior to its effectiveness.

The Company is an early stage company and has only just begun to implement its business plan. The likelihood of success of the Company must be considered in light of the expenses, complications and delays frequently encountered in connection with the establishment and expansion of new business and the competitive environment in which the Company will operate. The Companys long-term viability, profitability and growth will depend upon successful commercialization of the Nanotech Products and the development and commercialization of new products and services relative to its business plan. As an early stage company, the Company has little or no relevant operating history upon which an evaluation of its performance can be made. Such performance must be considered in light of the risks, expenses and difficulties frequently encountered in establishing new products, services and markets.

The Company’s business model is based on a two-tier strategy, which includes direct sales and licensing. The Company’s ultimate goal is to license its proprietary Green Polyurethane™ formulation to national and/or global coatings formulators and then focus on rolling out the commercialization of other Green Polyurethane™ applications such as adhesives and sealants. In order to achieve this, the Company is proving the validity of its products through direct sales and is therefore targeting large distributors and multiple client bases. The Company intends to focus within the Coatings, Adhesives, Sealants and Elastomers (“C.A.S.E.”) segment specifically for large industrial and commercial coatings applications where Green Polyurethane™ has a natural competitive advantage over other polyurethane ("PU") and epoxy coatings due to its superior chemical resistance and environmentally safe properties with reduced health risks.

As a result of the Nanotech Acquisition, Nanotech is now a wholly owned subsidiary of the Company. The Company intends to pursue the business of its Nanotech subsidiary and assume and execute Nanotechs business plan as its sole business. (See “Incorporation and Business of Nanotech” below).

The products manufactured and sold by the Company (“Nanotech Products”) comprise the following:

coatings and raw binder ingredients comprised of Green Polyurethane™ Monolithic Floor Coating and Green Polyurethane™ Binder and hereinafter referred to as “Coating Products”.

sealants and adhesives comprised of Green Polyurethane™ and hereinafter referred to as “Sealant Products”.

polyurethane foam for the textile industry in addition to environmentally safe coatings.

spray foam insulation

polyurethane foam packaging

synthetic leather, sealants and adhesives (“Added Applications”)

The Company was granted the right to manufacture and sell the Nanotech Products pursuant to an agreement (“Licensing Agreement”) entered into between the Company and Nanotech Industries Inc. (“NTI”), the holder of the proprietary rights to the license and intellectual property required for the manufacturing of the Nanotech Products. The Nanotech Products will target the coatings, adhesives, sealants and elastomers (“C.A.S.E.”) market in North America, Europe and Russian Territory (including the Russian Federation, Belorussia, Kazakhstan Republic) with an option to sell in Asia and the rest of the world pursuant to the terms of the Licensing Agreement.

   Company Address: 7901 Stoneridge Drive Pleasanton 94588 CA
   Company Phone Number: 270-4812   Stock Exchange / Ticker: NASDAQ HCTI
   HCTI is expected to report next financial results on March 27, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Healthcare Triangle Inc

Cloud Computing & Data Analytics Company Maintains Steady Performance in Third Quarter of 2023

Date: November 10, 2023
Healthcare Triangle Inc (HCTI), a renowned provider of digital transformation solutions for the healthcare and life sciences industries, recently released its financial results for the third quarter of 2023. Despite achieving a net loss of $0.000 million, compared to a deficit of $-2.339 million in the same reporting season last year, the company is showing signs of stability.
In terms of earnings per share, HCTI reached $0.00 per share for the third quarter, holding steady from the preceding reporting season. However, this is in line with the $0.00 per share achieved in the same quarter last year. It is important to note that these figures indicate a plateau in HCTI's financial performance rather than growth.

Healthcare Triangle Inc

Healthcare Triangle Inc Faces Financial Struggles, Stock Market Worries Grow

The healthcare industry is often regarded as a steadfast sector, resilient to economic fluctuations. However, recent financial reports from Healthcare Triangle Inc have raised concerns within the stock market. A closer look reveals a notable decline in revenue and an increase in the net shortfall for the most recent fiscal period.
Revenue Performance:
Healthcare Triangle Inc experienced a substantial decrease in revenue, with a decline of -26.424% to $8.53 million compared to $11.59 million in the previous year's reporting period. On a sequential basis, revenue deteriorated further by -13.336% from $9.84 million. These figures indicate a concerning trend for the company's financial health.

Healthcare Triangle Inc

Healthcare Triangle Inc Achieves Break-Even at $0.00 per Share in Fiscal Q1 2023, Despite Revenue Decline

Healthcare Triangle Inc is a health-tech company that specializes in developing innovative solutions for the healthcare industry. The company has been in operation for several years, and over time has made a name for itself as a reliable provider of value-based healthcare solutions.
The company recently released the financial results for its fiscal first quarter of 2023. According to the report, Healthcare Triangle Inc reached break-even of $0.00 per share, a significant improvement from the previous year's $-0.06 per share and the previous financial reporting period's $0.07 per share. Despite the improvement in earnings, the company's revenue decreased in double digits by -11.017% to $9.84 million, a decrease from $11.06 million in the comparable financial reporting period a year before. Sequentially, revenue deteriorated by -12.876% from $11.29 million.



About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com